Z. Seidl

发表

Thalamic atrophy is associated with development of clinically definite multiple sclerosis.

M. Dwyer, R. Zivadinov, E. Havrdová, 2013, Radiology.

Reliable measurements of brain atrophy in individual patients with multiple sclerosis

Saurabh Jain, D. Smeets, W. van Hecke, 2016, Brain and behavior.

The examination of the temporomandibular joint on 1,5T magnetic resonance.

R. Jirman, J. Mazánek, Z. Seidl, 2004, Prague medical report.

Thalamic Iron Differentiates Primary-Progressive and Relapsing-Remitting Multiple Sclerosis

C Langkammer, C. Langkammer, P. Dušek, 2017, American Journal of Neuroradiology.

Multiple Sclerosis and the Accumulation of Iron in the Basal Ganglia: Quantitative Assessment of Brain Iron Using MRI T2 Relaxometry

D. Horáková, J. Krasensky, M. Vaněčková, 2010, European Neurology.

Development of gray matter atrophy in relapsing–remitting multiple sclerosis is not gender dependent: Results of a 5-year follow-up study

Robert Zivadinov, Niels Bergsland, Michael G. Dwyer, 2013, Clinical Neurology and Neurosurgery.

Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case–control study

J. L. Cox, S. Hussein, M. Dwyer, 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

Methanol Poisoning as an Acute Toxicological Basal Ganglia Lesion Model: Evidence from Brain Volumetry and Cognition.

T. Kober, E. Růžička, B. Maréchal, 2019, Alcoholism, clinical and experimental research.

Protective associations of HDL with blood-brain barrier injury in multiple sclerosis patients[S]

M. Ramanathan, R. Browne, R. Zivadinov, 2015, Journal of Lipid Research.

Multiple sclerosis susceptibility loci do not alter clinical and MRI outcomes in clinically isolated syndrome

C. Guttmann, P. D. Jager, E. Havrdová, 2013, Genes and Immunity.

Reduced hypothalamic gray matter in narcolepsy with cataplexy.

S. Nevsimalova, K. Šonka, J. Bušková, 2006, Neuro endocrinology letters.

The impact of co-morbidities on a 6-year survival after methanol mass poisoning outbreak: possible role of metabolic formaldehyde

L. Vojtová, J. Hubacek, J. Bydžovský, 2020, Clinical toxicology.

Longitudinal MRI and neuropsychological assessment of patients with clinically isolated syndrome

D. Ramasamy, R. Benedict, R. Zivadinov, 2014, Journal of Neurology.

A Novel Semiautomated Pipeline to Measure Brain Atrophy and Lesion Burden in Multiple Sclerosis: A Long‐Term Comparative Study

M. Dwyer, R. Zivadinov, E. Havrdová, 2017, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

Leukotriene-mediated neuroinflammation, toxic brain damage, and neurodegeneration in acute methanol poisoning

O. Nurieva, D. Pelclova, M. Vaněčková, 2017, Clinical toxicology.

Efficacy of repetitive transcranial magnetic stimulation for the treatment of refractory chronic tinnitus: a randomized, placebo controlled study.

R. Jech, J. Raboch, M. Vaněčková, 2010, Neuro endocrinology letters.

Gray matter atrophy patterns in multiple sclerosis: A 10-year source-based morphometry study

M. Dwyer, R. Zivadinov, E. Havrdová, 2017, NeuroImage: Clinical.

Interferon, azathioprine and corticosteroids in multiple sclerosis: 6-year follow-up of the ASA cohort

E. Havrdová, D. Horáková, T. Kalincik, 2012, Clinical Neurology and Neurosurgery.

Humoral responses to herpesviruses are associated with neurodegeneration after a demyelinating event: Results from the Multi-Center SET study

M. Ramanathan, M. Dwyer, R. Zivadinov, 2014, Journal of Neuroimmunology.

Interactions of serum cholesterol with anti-herpesvirus responses affect disease progression in clinically isolated syndromes

M. Ramanathan, D. Ramasamy, R. Zivadinov, 2013, Journal of Neuroimmunology.

Serum lipoprotein composition and vitamin D metabolite levels in clinically isolated syndromes: Results from a multi-center study

M. Ramanathan, R. Browne, D. Ramasamy, 2014, The Journal of Steroid Biochemistry and Molecular Biology.

Role of activation of lipid peroxidation in the mechanisms of acute methanol poisoning*

M. Vaněčková, Z. Seidl, T. Navrátil, 2018, Clinical toxicology.

Volume of the amygdala is reduced in patients with narcolepsy - a structural MRI study.

A. Rulseh, D. Horínek, C. Nimsky, 2011, Neuro endocrinology letters.

Is no evidence of disease activity an achievable goal in MS patients on intramuscular interferon beta-1a treatment over long-term follow-up?

D. Ramasamy, R. Zivadinov, E. Havrdová, 2017, Multiple sclerosis.

Post-mortem magnetic resonance imaging and its irreplaceable role in determining CNS malformation (hydranencephaly) – Case report

I. Vítková, M. Vaněčková, Z. Seidl, 2010, Brain and Development.

Is it always possible to determine a diagnosis? Prenatal ultrasonography, post mortem magnetic resonance, autopsy.

I. Vítková, M. Vaněčková, Z. Seidl, 2010, Neuro endocrinology letters.

Benefits of examination by post mortem performed magnetic resonance imaging of foetus: haemorrhage in germinal matrix.

I. Vítková, M. Vaněčková, Z. Seidl, 2010, Neuro endocrinology letters.

Meningocerebral Angiodysplasia: Post-Mortem Magnetic Resonance Imaging and Autopsy

I. Vítková, M. Vaněčková, Z. Seidl, 2009, The neuroradiology journal.

Apolipoproteins are associated with new MRI lesions and deep grey matter atrophy in clinically isolated syndromes

M. Ramanathan, R. Browne, D. Ramasamy, 2014, Journal of Neurology, Neurosurgery & Psychiatry.

Adipose tissue distribution in obese females. Relationship to androgens, cortisol, growth hormone and leptin.

M. Kunesova, V. Hainer, J. Pařízková, 2002, Sbornik lekarsky.

Secondary-progressive form of multiple sclerosis: MRI changes versus clinical status.

E. Havrdová, J. Krasensky, M. Vaněčková, 2008, Neuro endocrinology letters.

Acute Methanol Poisoning: Prevalence and Predisposing Factors of Haemorrhagic and Non‐Haemorrhagic Brain Lesions

O. Nurieva, D. Pelclova, M. Vaněčková, 2016, Basic & clinical pharmacology & toxicology.

Neuroinflammation markers and methyl alcohol induced toxic brain damage.

L. Vojtová, J. Hubacek, O. Nurieva, 2018, Toxicology Letters.

Efficiency of 123I-ioflupane SPECT as a marker of basal ganglia damage in acute methanol poisoning: a six-year prospective study

M. Vaněčková, Z. Seidl, T. Navrátil, 2020 .

Cervical Meningioma in Childhood

J. Zamecnik, M. Vaněčková, Z. Seidl, 2008, The neuroradiology journal.

Clinical and genetic determinants of chronic visual pathway changes after methanol - induced optic neuropathy: four-year follow-up study

L. Vojtová, J. Hubacek, J. Bydžovský, 2018, Clinical toxicology.

Rare Alleles within the CYP2E1 (MEOS System) Could be Associated with Better Short‐Term Health Outcome after Acute Methanol Poisoning

E. Růžička, J. Klempír, J. Hubacek, 2015, Basic & clinical pharmacology & toxicology.

HLA DRB1*1501 is only modestly associated with lesion burden at the first demyelinating event

M. Ramanathan, S. Hussein, R. Zivadinov, 2011, Journal of Neuroimmunology.

Imaging findings after methanol intoxication (cohort of 46 patients).

E. Růžička, H. Brožová, J. Klempír, 2015, Neuro endocrinology letters.

Osteoblastoma in a lumbar vertebral body

Z. Seidl, J. Plas, J. Obenberger, 1999, Neuroradiology.

Successful Use of Hydroxocobalamin and Sodium Thiosulfate in Acute Cyanide Poisoning: A Case Report with Follow‐up

D. Pelclova, M. Vaněčková, Z. Seidl, 2015, Basic & clinical pharmacology & toxicology.

Efficiency of 123I-ioflupane SPECT as the marker of basal ganglia damage in acute methanol poisoning: 6-year prospective study

H. Brožová, M. Vaněčková, Z. Seidl, 2020, Clinical toxicology.

J. Bydžovský, M. Balík, D. Pelclova, 2020, Clinical toxicology.

Progressive Chronic Retinal Axonal Loss Following Acute Methanol-induced Optic Neuropathy: Four-Year Prospective Cohort Study.

J. Bydžovský, O. Nurieva, D. Pelclova, 2018, American journal of ophthalmology.

Czech mass methanol outbreak 2012: Epidemiology, challenges and clinical features

J. Klempír, J. Hubacek, O. Nurieva, 2014, Clinical toxicology.

Cognitive sequelae of methanol poisoning involve executive dysfunction and memory impairment in cross-sectional and long-term perspective.

E. Růžička, J. Klempír, I. Lišková, 2017, Alcohol.

Long-term visual damage after acute methanol poisonings: Longitudinal cross-sectional study in 50 patients

E. Růžička, J. Klempír, O. Bezdicek, 2015, Clinical toxicology.

A case of an epignathus with intracranial extension appearing as a persistently open mouth at 16 weeks and subsequently diagnosed at 20 weeks of gestation

I. Vítková, M. Vaněčková, Z. Seidl, 2011, Journal of clinical ultrasound : JCU.

Serum lipid profile changes predict neurodegeneration in interferon-β1a-treated multiple sclerosis patients[S]

M. Ramanathan, R. Zivadinov, B. Weinstock-Guttman, 2017, Journal of Lipid Research.

Lipid profiles are associated with lesion formation over 24 months in interferon-β treated patients following the first demyelinating event

M. Ramanathan, S. Hussein, R. Zivadinov, 2013, Journal of Neurology, Neurosurgery & Psychiatry.

Longitudinal Mixed-Effect Model Analysis of the Association between Global and Tissue-Specific Brain Atrophy and Lesion Accumulation in Patients with Clinically Isolated Syndrome

M. Dwyer, R. Zivadinov, E. Havrdová, 2015, American Journal of Neuroradiology.

Coincidence of spinal tumor (astrocytoma) and non-specific encephalomyelitis.

M. Vaněčková, Z. Seidl, A. Burgetová, 2012, Neuro endocrinology letters.

Intracranial Lipomas: A Retrospective Study

M. Vaněčková, Z. Seidl, T. Viták, 2007, The neuroradiology journal.

Posterior Reversible Encephalopathy Syndrome (PRES) in 5-year-old girl with nephrotic syndrome.

J. Zeman, M. Vaněčková, Z. Seidl, 2010, Neuro endocrinology letters.

Hippocampal but not amygdalar volume loss in narcolepsy with cataplexy.

A. Rulseh, K. Šonka, J. Bušková, 2015, Neuro endocrinology letters.

Increased albumin quotient (QAlb) in patients after first clinical event suggestive of multiple sclerosis is associated with development of brain atrophy and greater disability 48 months later

M. Ramanathan, R. Zivadinov, B. Weinstock-Guttman, 2016, Multiple sclerosis.

Apolipoprotein E ε4-positive multiple sclerosis patients develop more gray-matter and whole-brain atrophy: a 15-year disease history model based on a 4-year longitudinal study.

S. Hussein, R. Zivadinov, E. Havrdová, 2010, Folia biologica.

Neurologie pro studium i praxi

Z. Seidl, J. Obenberger, 2004 .

Environmental Factors Associated with Disease Progression after the First Demyelinating Event: Results from the Multi-Center SET Study

M. Ramanathan, S. Hussein, M. Dwyer, 2013, PloS one.

Randomized study of interferon beta-1a, low-dose azathioprine, and low-dose corticosteroids in multiple sclerosis

R. Zivadinov, L. Dušek, E. Havrdová, 2009, Multiple sclerosis.

A serial 10-year follow-up study of brain atrophy and disability progression in RRMS patients

D. Ramasamy, M. Dwyer, R. Zivadinov, 2016, Multiple sclerosis.

Corpus Callosum Atrophy – A Simple Predictor of Multiple Sclerosis Progression: A Longitudinal 9-Year Study

E. Havrdová, D. Horáková, T. Kalincik, 2012, European Neurology.

Gray matter atrophy and disability progression in patients with early relapsing–remitting multiple sclerosis A 5-year longitudinal study

Robert Zivadinov, Niels Bergsland, Michael G. Dwyer, 2009, Journal of the Neurological Sciences.

Macroprolactinomas: retrospective follow up study in the MR imaging and correlation with clinical symptomatology.

M. Vaněčková, Z. Seidl, V. Hána, 2007, Neuro endocrinology letters.

Amygdalar volume and psychiatric symptoms in Alzheimer's disease: an MRI analysis

J. Hort, M. Bojar, J. Krasensky, 2006, Acta neurologica Scandinavica.

Long-term effectiveness of natalizumab on MRI outcomes and no evidence of disease activity in relapsing-remitting multiple sclerosis patients treated in a Czech Republic real-world setting: A longitudinal, retrospective study.

W. van Hecke, A. Ribbens, T. Billiet, 2020, Multiple sclerosis and related disorders.

Early magnetic resonance imaging predictors of clinical progression after 48 months in clinically isolated syndrome patients treated with intramuscular interferon β‐1a

D. Ramasamy, R. Zivadinov, E. Havrdová, 2015, European journal of neurology.

Volumetric MRI Markers and Predictors of Disease Activity in Early Multiple Sclerosis: A Longitudinal Cohort Study

Dana Horakova, Tomas Kalincik, E. Havrdová, 2012, PloS one.

Magnetic resonance volumetry of pathological brain foci in patients with systemic lupus erythematosus.

C. Dostál, J. Krasensky, Z. Seidl, 2008, Clinical and experimental rheumatology.

Concurrent occurrence of multiple sclerosis and primary CNS lymphoma: a case report.

M. Vaněčková, Z. Seidl, A. Burgetová, 2008, Neuro endocrinology letters.

MRI correlates of disability progression in patients with CIS over 48 months

Robert Zivadinov, Niels Bergsland, Dana Horakova, 2014, NeuroImage: Clinical.

Evolution of Cortical and Thalamus Atrophy and Disability Progression in Early Relapsing-Remitting MS during 5 Years

S. Hussein, M. Dwyer, R. Zivadinov, 2013, American Journal of Neuroradiology.

Combining clinical and magnetic resonance imaging markers enhances prediction of 12-year disability in multiple sclerosis

Robert Zivadinov, Dana Horakova, Lukas Sobisek, 2017, Multiple sclerosis.

Relationship between gray matter volume and cognitive learning in CIS patients on disease-modifying treatment

D. Ramasamy, R. Benedict, R. Zivadinov, 2014, Journal of the Neurological Sciences.

Identification of multiple sclerosis patients at highest risk of cognitive impairment using an integrated brain magnetic resonance imaging assessment approach

M. Sormani, E. Havrdová, D. Horáková, 2017, European journal of neurology.

Cognitive clinico‐radiological paradox in early stages of multiple sclerosis

M. Sormani, D. Horáková, T. Uher, 2017, Annals of clinical and translational neurology.

Pathological cut-offs of global and regional brain volume loss in multiple sclerosis

Eva Kubala Havrdova, Robert Zivadinov, Niels Bergsland, 2019, Multiple sclerosis.

Early predictors of non‐response to interferon in multiple sclerosis

E. Havrdová, D. Horáková, T. Kalincik, 2012, Acta neurologica Scandinavica.

Lipid pro fi les are associated with lesion formation over 24 months in interferon-β treated patients following the fi rst demyelinating event

M. Ramanathan, S. Hussein, R. Zivadinov, 2013 .

Bimonthly Evolution of Cortical Atrophy in Early Relapsing-Remitting Multiple Sclerosis over 2 Years: A Longitudinal Study

D. Ramasamy, M. Dwyer, R. Zivadinov, 2013, Multiple sclerosis international.

The Role of High‐Frequency MRI Monitoring in the Detection of Brain Atrophy in Multiple Sclerosis

M. Dwyer, R. Zivadinov, N. Bergsland, 2018, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

Patients’ Stratification and Correlation of Brain Magnetic Resonance Imaging Parameters with Disability Progression in Multiple Sclerosis

E. Havrdová, D. Horáková, J. Krasensky, 2009, European Neurology.

Environmental Factors Associated with Disease Progression after the First Demyelinating Event: Results from the Multi-Center SET Study (P05.134)

M. Ramanathan, S. Hussein, M. Dwyer, 2013 .

Gadobenate dimeglumine and gadofosveset trisodium for MR angiography of the renal arteries: Multicenter intraindividual crossover comparison.

D. Bilecen, J. Vymazal, R. Iezzi, 2010, AJR. American journal of roentgenology.

Osmotic Demyelination Syndrome (Central Pontine and Extrapontine Myelinolysis with Coagulative Necrosis of the Putamina and Cortical Laminar Necrosis)

M. Vaněčková, Z. Seidl, A. Burgetová, 2008, The neuroradiology journal.

Does Higher Gadolinium Concentration Play a Role in the Morphologic Assessment of Brain Tumors? Results of a Multicenter Intraindividual Crossover Comparison of Gadobutrol versus Gadobenate Dimeglumine (the MERIT Study)

G Schneider, J. Vymazal, C. Colosimo, 2012, American Journal of Neuroradiology.

Metachromatic leukodystrophy: magnetic resonance imaging (diffusion weighted image--DWI).

M. Vaněčková, Z. Seidl, T. Viták, 2008, Neuro endocrinology letters.

Subcortical and Cortical Gray Matter Atrophy in a Large Sample of Patients with Clinically Isolated Syndrome and Early Relapsing-Remitting Multiple Sclerosis

M. Dwyer, R. Zivadinov, E. Havrdová, 2012, American Journal of Neuroradiology.

Detection of cortical lesions is dependent on choice of slice thickness in patients with multiple sclerosis.

David Fritz, A. Minagar, M. Dwyer, 2007, International review of neurobiology.

Rare Alleles within the CYP2E1 (MEOS System) Could be Associated with Better Short‐Term Health Outcome after Acute Methanol Poisoning

E. Růžička, J. Klempír, J. Hubacek, 2015, Basic & clinical pharmacology & toxicology.

Protective associations of HDL with blood-brain barrier injury in multiple sclerosis patients patient-oriented and epidemiological research

M. Ramanathan, R. Browne, R. Zivadinov, 2020 .